Latest filing published 27 Nov 2019 for Traws Pharma, Inc., €45k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Viren Mehta has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Traws Pharma, Inc. and OSI Pharmaceuticals Inc. Over a trading history stretching from 16 March 2006 to 25 November 2019, the count stands at 23 filings.
On the market, this insider has only ever bought: 2 purchases, €234k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 5 share grants. Since January 2019: 1 purchase and no sales on the market.
The record was last updated on 27 November 2019 with an open-market purchase (€45k) in Traws Pharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations